10/14/2026
Ibogaine's potential in addiction treatment faces cardiac risks
New review highlights ibogaine's promise and dangers in addiction therapy.
Topic archive
university of miami
16 stories
10/9/2026
FDA faces internal dissent over HHS peptide legalization
HHS plans to allow unapproved peptides, sparking FDA staff concerns.
10/6/2026
DemeRx appoints ibogaine expert Juan Sanchez-Ramos
Sanchez-Ramos joins as DemeRx advances its alcohol use disorder program.
9/14/2026
Psyence BioMed forms Texas entity for U.S. ibogaine research
Texas Ibogaine Research Corporation to spearhead U.S. ibogaine development efforts.
9/10/2026
Rhelion Life Sciences launches ibogaine stability program
Filament Health begins stability program for IBEX011 amid rising ibogaine demand.
9/10/2026
Filament Health plans stability program for ibogaine drug
IBEX011 stability program aims to meet growing demand for standardized ibogaine.
8/26/2026
University of Miami gifts 1994 ibogaine IND to HHS
The move promotes open science and could influence future psychedelic research.
8/21/2026
University of Miami gifts ibogaine application to Trump admin
The move could expedite psychedelic research for veteran treatment.
8/21/2026
Ibogaine research gains momentum for PTSD treatment
Trump administration accelerates psychedelic research for veterans' mental health.
8/19/2026
Ibogaine biotech stocks rise after Trump comments
University of Miami's 1994 ibogaine application resurfaces, boosting market interest.
8/19/2026
Trump pushes ibogaine treatment for veterans
Trump's administration advances psychedelic therapies for PTSD and TBI in veterans.
8/19/2026
Psyence BioMed supports U.S. push for ibogaine development
U.S. federal actions could accelerate ibogaine's medical potential
8/19/2026
Psyence BioMed backs Trump ibogaine initiative
Company aligns with U.S. efforts to advance ibogaine research.
8/19/2026
Trump highlights ibogaine research in executive order
Ibogaine, a psychedelic drug, gains federal attention for treating addiction.
8/19/2026
University of Miami submits ibogaine application to federal authorities
Trump announces transfer of ibogaine investigational drug application to accelerate research.
8/18/2026
University of Miami gifts ibogaine application to FDA
The move aims to expedite ibogaine research under a new executive order.